Unique stem cell line identifier | FSMi001-A |
---|---|
Alternative name(s) of stem cell line | FSM-SPG31-2 |
Institution | Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone (PI), Italy |
Contact information of distributor | Matteo Baggiani – matteo.baggiani@fsm.unipi.it |
Devid Damiani – devid.damiani@fsm.unipi.it | |
Type of cell line | hiPSC |
Origin | Human |
Additional origin info required for human ESC or iPSC | Age: 47 years Sex: Female Ethnicity: Caucasian |
Cell Source | Skin fibroblasts |
Clonality | Clonal |
Method of reprogramming | Episomal vectors encoding OCT4/sh-p53, SOX2/KLF4, EBNA-1, and L-MYC/LIN28 |
Genetic Modification | NO |
Type of Genetic Modification | None |
Evidence of the reprogramming transgene loss (including genomic copy if applicable) | RT/qPCRs for plasmid-specific transcripts show no expression for reprogramming genes |
Associated disease | SPG31 (Spastic Paraplegia 31) |
Gene/locus | REEP1 (c.337C > T; p. Arg113*) |
Date archived/stock date | 03 July 2013 |
Cell line repository/bank | https://hspcreg.eu/cell-line/FSMi001-A |
Ethical approval | Written informed consent was obtained from patient |